Literature DB >> 35152062

Interaction of A3 adenosine receptor ligands with the human multidrug transporter ABCG2.

Biebele Abel1, Megumi Murakami1, Dilip K Tosh2, Jinha Yu2, Sabrina Lusvarghi1, Ryan G Campbell2, Zhan-Guo Gao2, Kenneth A Jacobson3, Suresh V Ambudkar4.   

Abstract

Various adenosine receptor nucleoside-like ligands were found to modulate ATP hydrolysis by the multidrug transporter ABCG2. Both ribose-containing and rigidified (N)-methanocarba nucleosides (C2-, N6- and 5'-modified), as well as adenines (C2-, N6-, and deaza modified), were included. 57 compounds out of 63 tested either stimulated (50) or inhibited (7) basal ATPase activity. Structure-activity analysis showed a separation of adenosine receptor and ABCG2 activities. The 7-deaza modification had favorable effects in both (N)-methanocarba nucleosides and adenines. Adenine 37c (MRS7608) and (N)-methanocarba 7-deaza-5'-ethyl ester 60 (MRS7343) were found to be potent stimulators of ABCG2 ATPase activity with EC50 values of 13.2 ± 1.7 and 13.2 ± 2.2 nM, respectively. Both had affinity in the micromolar range for A3 adenosine receptor and lacked the 5'-amide agonist-enabling group (37c was reported as a weak A3 antagonist, Ki 6.82 μM). Compound 60 significantly inhibited ABCG2 substrate transport (IC50 0.44 μM). Docking simulations predicted the interaction of 60 with 21 residues in the drug-binding pocket of ABCG2.
Copyright © 2022. Published by Elsevier Masson SAS.

Entities:  

Keywords:  A(3) adenosine receptor; ABC transporter; ABCG2; ATP hydrolysis; Drug transport; Multidrug resistance

Mesh:

Substances:

Year:  2022        PMID: 35152062      PMCID: PMC8893036          DOI: 10.1016/j.ejmech.2022.114103

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  40 in total

Review 1.  Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies.

Authors:  Eduardo E Chufan; Hong-May Sim; Suresh V Ambudkar
Journal:  Adv Cancer Res       Date:  2015-01-08       Impact factor: 6.242

2.  Structural Basis of Drug Recognition by the Multidrug Transporter ABCG2.

Authors:  Julia Kowal; Dongchun Ni; Scott M Jackson; Ioannis Manolaridis; Henning Stahlberg; Kaspar P Locher
Journal:  J Mol Biol       Date:  2021-04-08       Impact factor: 5.469

3.  PyMod 2.0: improvements in protein sequence-structure analysis and homology modeling within PyMOL.

Authors:  Giacomo Janson; Chengxin Zhang; Maria Giulia Prado; Alessandro Paiardini
Journal:  Bioinformatics       Date:  2017-02-01       Impact factor: 6.937

4.  Truncated Nucleosides as A(3) Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane Substitutions.

Authors:  Dilip K Tosh; Silvia Paoletta; Khai Phan; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  ACS Med Chem Lett       Date:  2012-06-11       Impact factor: 4.345

5.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation.

Authors:  Youngjin Kim; Jue Chen
Journal:  Science       Date:  2018-01-25       Impact factor: 47.728

7.  Drug-stimulatable ATPase activity in crude membranes of human MDR1-transfected mammalian cells.

Authors:  S V Ambudkar
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

8.  Structure-Based Design, Synthesis by Click Chemistry and in Vivo Activity of Highly Selective A3 Adenosine Receptor Agonists.

Authors:  Dilip K Tosh; Silvia Paoletta; Zhoumou Chen; Steven Crane; John Lloyd; Zhan-Guo Gao; Elizabeth T Gizewski; John A Auchampach; Daniela Salvemini; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2015       Impact factor: 3.597

9.  Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists.

Authors:  Dilip K Tosh; Antonella Ciancetta; Philip Mannes; Eugene Warnick; Aaron Janowsky; Amy J Eshleman; Elizabeth Gizewski; Tarsis F Brust; Laura M Bohn; John A Auchampach; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  ACS Omega       Date:  2018-10-04

Review 10.  Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications.

Authors:  Yu Toyoda; Tappei Takada; Hiroshi Suzuki
Journal:  Front Pharmacol       Date:  2019-03-05       Impact factor: 5.810

View more
  1 in total

1.  Network Pharmacology Exploration Reveals Gut Microbiota Modulation as a Common Therapeutic Mechanism for Anti-Fatigue Effect Treated with Maca Compounds Prescription.

Authors:  Hongkang Zhu; Ruoyong Wang; Hanyi Hua; Yuliang Cheng; Yahui Guo; He Qian; Peng Du
Journal:  Nutrients       Date:  2022-04-07       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.